U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035964) titled 'Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability' on June 06.
Brief Summary: The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females
Study Start Date: June 04
Study Type: INTERVENTIONAL
Condition:
Gut Permeability
Gut Health
Intervention:
DIETARY_SUPPLEMENT: human lactoferrin
effera human lactoferrin
DIETARY_SUPPLEMENT: Placebo
Placebo Control
Recruitment Status: RECRUITING
Sponsor: Helaina Inc.
Disclaimer: Curated by HT Syndication....